Hoosik Min of Pine Investment Advisory presented his in-depth investment thesis on Daihan Pharmaceutical (KOSDAQ: 023910) at Asian Investing Summit 2018. Daihan is a manufacturer of infusions.
The full session is available exclusively to members of MOI Global.
Members, log in below to access the full session.
Not a member?
Thank you for your interest. Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:
About the instructor:
Hoosik (Michael) Min holds a B.A from Hankuk University of Foreign Studies and an M.B.A. in Finance from the University of Denver. Michael began his career in 1989 as an IT sector analyst at Coryo Securities, Tongyang Securities, Dongwon Securities, and Korea Investment & Securities. After 2007, he served as CIO in the Asset Management Department of Tempis Capital Management for three years and founded Pine Investment Advisory in 2010. He serves as chief investment officer.